Blackstone Inc’s Revolution Medicines RVMD Stock Holding History

Blackstone Inc’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$344K	Buy	+3,539	New	+$357K	﹤0.01%	332
2024 Q2	–	Sell	-37,197	Closed	-$1.2M	–	193
2024 Q1	$1.2M	Hold	37,197	–	–	﹤0.01%	135
2023 Q4	$1.07M	Hold	37,197	–	–	﹤0.01%	111
2023 Q3	$1.03M	Hold	37,197	–	–	﹤0.01%	121
2023 Q2	$995K	Hold	37,197	–	–	﹤0.01%	124
2023 Q1	$806K	Buy	37,197 +6,081	+20%	+$150K	﹤0.01%	130
2022 Q4	$741K	Buy	31,116 +6,428	+26%	+$137K	﹤0.01%	112
2022 Q3	$487K	Buy	24,688 +7,500	+44%	+$165K	﹤0.01%	157
2022 Q2	$335K	Hold	17,188	–	–	﹤0.01%	199
2022 Q1	$438K	Hold	17,188	–	–	﹤0.01%	200
2021 Q4	$433K	Hold	17,188	–	–	﹤0.01%	352
2021 Q3	$473K	Sell	17,188 -399,441	-96%	-$11.6M	﹤0.01%	411
2021 Q2	$13.2M	Buy	+416,629	New	+$14.5M	0.03%	125

Other funds holding RVMD

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Blackstone Inc's RVMD Position: Q1 2026 in Review

Blackstone Inc opened a new position in Revolution Medicines (RVMD) in Q1 2026: 3,539 shares worth $344K. The stake represents ﹤0.01% of the portfolio and ranks #332 among its holdings. This is a return to the name: Blackstone Inc previously reported a position in RVMD as recently as Q1 2024.

Blackstone Inc first reported a position in RVMD in Q2 2021 and has held it in 13 quarters since. The position peaked at $13.2M in Q2 2021. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

Blackstone Inc held 3,539 shares of Revolution Medicines worth $344K as of Q1 2026.
Revolution Medicines was a new Blackstone Inc position in Q1 2026.
Revolution Medicines made up ﹤0.01% of Blackstone Inc's portfolio in Q1 2026, its #332 holding.
Blackstone Inc first reported a position in Revolution Medicines in Q2 2021 and has held it in 13 quarters since.
Blackstone Inc's Revolution Medicines position peaked at $13.2M in Q2 2021.
512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Blackstone Inc's 13F filing for Q1 2026, filed 15 May 2026.